Sign In
Buy NTLA
$12.02
+0.0800 (+0.670%)
At Close: Aug 10, 2026
Exelixis (EXEL) Received its Third Buy in a Row
02:32am, Tuesday, 21'st Apr 2020
After Piper Sandler and RBC Capital gave Exelixis (NASDAQ: EXEL) a Buy rating last month, the company received another Buy,
Oppenheimer Believes Seattle Genetics (SGEN) Won't Stop Here
01:46am, Monday, 20'th Apr 2020
Oppenheimer analyst Silvan Tuerkcan maintained a Buy rating on Seattle Genetics (SGEN) yesterday and set a price target of $146.00. The company's shares
Oppenheimer Believes Seattle Genetics (NASDAQ: SGEN) Won’t Stop Here
01:46am, Monday, 20'th Apr 2020
Oppenheimer analyst Silvan Tuerkcan maintained a Buy rating on Seattle Genetics (SGEN – Research Report) yesterday and set a price
Intellia Therapeutics Inc (NASDAQ:NTLA) Stock Holdings Lifted by Bank of New York Mellon Corp
08:14am, Sunday, 19'th Apr 2020
Bank of New York Mellon Corp increased its holdings in Intellia Therapeutics Inc (NASDAQ:NTLA) by 4.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 223,967
Intellia Therapeutics Getting Closer To Key Technical Measure
07:00am, Friday, 17'th Apr 2020
A Relative Strength Rating upgrade for Intellia Therapeutics shows improving technical performance. Will it continue?
Intellia Therapeutics Inc (NASDAQ:NTLA) Given Consensus Recommendation of "Buy" by Brokerages
12:36pm, Thursday, 16'th Apr 2020
Shares of Intellia Therapeutics Inc (NASDAQ:NTLA) have been assigned an average recommendation of “Buy” from the ten brokerages that are currently covering the stock, MarketBeat Ratings reports. F
Exchange Traded Concepts LLC Grows Stock Holdings in Intellia Therapeutics Inc (NASDAQ:NTLA)
10:14am, Thursday, 16'th Apr 2020
Exchange Traded Concepts LLC raised its position in shares of Intellia Therapeutics Inc (NASDAQ:NTLA) by 98.8% during the first quarter, according to its most recent disclosure with the Securities & E
How Does Intellia Therapeutics, Inc. (NASDAQ:NTLA) Affect Your Portfolio Volatility?
04:00pm, Monday, 13'th Apr 2020
If you own shares in Intellia Therapeutics, Inc. (NASDAQ:NTLA) then it's worth thinking about how it contributes to...
UBS Asset Management Americas Inc. Sells 1,749 Shares of Intellia Therapeutics Inc (NASDAQ:NTLA)
10:52am, Monday, 13'th Apr 2020
UBS Asset Management Americas Inc. lessened its position in shares of Intellia Therapeutics Inc (NASDAQ:NTLA) by 4.1% in the fourth quarter, according to the company in its most recent disclosure with
Zacks Investment Research Downgrades Intellia Therapeutics (NASDAQ:NTLA) to Hold
05:38am, Monday, 13'th Apr 2020
Intellia Therapeutics (NASDAQ:NTLA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday, Zacks.com reports. Ac
Zacks Investment Research Upgrades Intellia Therapeutics (NASDAQ:NTLA) to "Buy"
08:38am, Friday, 10'th Apr 2020
Intellia Therapeutics (NASDAQ:NTLA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Friday, Zacks.com reports. The brokerage cur
AQR Capital Management LLC Has $875,000 Holdings in Intellia Therapeutics Inc (NASDAQ:NTLA)
08:32am, Thursday, 09'th Apr 2020
AQR Capital Management LLC increased its stake in shares of Intellia Therapeutics Inc (NASDAQ:NTLA) by 63.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the
Does Market Volatility Impact Intellia Therapeutics, Inc.’s (NASDAQ:NTLA) Share Price?
03:16pm, Wednesday, 08'th Apr 2020
If you're interested in Intellia Therapeutics, Inc. (NASDAQ:NTLA), then you might want to consider its beta (a measure...
Alnylam, Dicerna Join Forces to Take on Arrowhead
10:26pm, Monday, 06'th Apr 2020
Companies in race to find treatment for genetic disease that can cause lung and liver disease Continue reading...
Alnylam, Dicerna Join Forces to Take on Arrowhead
09:27pm, Monday, 06'th Apr 2020
Alnylam, Dicerna Join Forces to Take on Arrowhead, Stocks: ALNY,DRNA,ARWR,NTLA,VRTX,NVO,ALXN,LLY,RHHBY, release date:Apr 06, 2020
